{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T04:17:18Z","timestamp":1746591438102,"version":"3.37.3"},"reference-count":26,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"Federal Institute for Drugs and Medical Devices"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2019,4,3]]},"DOI":"10.1080\/03007995.2018.1541317","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T11:35:41Z","timestamp":1540553741000},"page":"697-704","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implications"],"prefix":"10.1080","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6815-0780","authenticated-orcid":false,"given":"Iva","family":"Selke Krulichov\u00e1","sequence":"first","affiliation":[{"name":"Department of Medical Biophysics, Faculty of Medicine in Hradec Kr\u00e1lov\u00e9, Charles University, Hradec Kr\u00e1lov\u00e9, Czech Republic;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9614-9875","authenticated-orcid":false,"given":"Gisbert W.","family":"Selke","sequence":"additional","affiliation":[{"name":"AOK Research Institute (WIdO), Berlin, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Eichler","sequence":"additional","affiliation":[{"name":"AOK Research Institute (WIdO), Berlin, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronika","family":"Lappe","sequence":"additional","affiliation":[{"name":"PMV research group, Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy of Children and Adolescents, Cologne University, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6539-6972","authenticated-orcid":false,"given":"Brian","family":"Godman","sequence":"additional","affiliation":[{"name":"Strathclyde Institute of Pharmacy and Biomedical Sciences, Strathclyde University, Glasgow, UK;"},{"name":"Health Economics Centre, Liverpool University Management School, Liverpool, UK;"},{"name":"Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden;"},{"name":"Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Garankuwa, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2191-1773","authenticated-orcid":false,"given":"Ingrid","family":"Schubert","sequence":"additional","affiliation":[{"name":"PMV research group, Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy of Children and Adolescents, Cologne University, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"CIT0001","unstructured":"Boeschen D, G\u00fcnther J, Chytrek D, et\u00a0al. Pillenreport 2015. Ein Statusbericht zu oralen Kontrazeptiva. Bremen: Universit\u00e4t Bremen; 2015. 63 p"},{"key":"CIT0002","first-page":"32","volume":"16","author":"European Medicines Agency","year":"2014","journal-title":"EMA; January"},{"key":"CIT0003","unstructured":"European Medicines Agency. Benefits of combined hormonal contraceptives (CHC) continue to outweigh risks. Product information updated to help women make informed decisions about their choice of contraception. EMA 35464\/2014. London: EMA; January 16, 2014"},{"key":"CIT0004","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte. Abwehr von Gefahren durch Arzneimittel. Hier: Umsetzung des Durchf\u00fchrungsbeschlusses der Kommission K (2014)307 betreffend die Zulassung der Humanarzneimittel \u201eKombinierte hormonale Kontrazeptiva \u201cgem\u00e4\u00df Artikel 31 der Richtlinie 2001\/83\/EG (KHK-Bescheid an pharmazeutische Unternehmer). Bonn: 2014. Available at: https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Arzneimittel\/Pharmakovigilanz\/Risikoinformationen\/RisikoBewVerf\/g-l\/khk_bescheid.pdf?__blob=publicationFile&v=2 [Last accessed November 5, 2017]"},{"key":"CIT0005","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte. Patienteninformation. Bonn: 2014. Available at: https:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Arzneimittel\/Pharmakovigilanz\/Risikoinformationen\/RI_rhb\/2014\/rhb-khk-pi-card.pdf?__blob=publicationFile&v=3 [Last accessed November 5, 2017]"},{"key":"CIT0006","unstructured":"Rote Hand Brief of 30th Jan 2014. Kombinierte hormonale Kontrazeptiva: Unterschiede hinsichtlich des Thromboembolierisikos verschiedener Pr\u00e4parate, Bedeutung von individuellen Risikofaktoren und Beachtung von Anzeichen und Symptomen. Bonn: 2014. Available at: https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RHB\/2014\/rhb-khk.pdf?__blob=publicationFile&v=7 [Last accessed November 5, 2017]"},{"key":"CIT0007","first-page":"CD010813","volume":"3","author":"de Bastos M","year":"2014","journal-title":"Cochrane Database System Rev"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2135"},{"key":"CIT0009","unstructured":"Glaeske G, Schicktanz C. BARMER-GEK Arzneimittelreport 2011. Auswertungsergebnisse der BARMER GEK Arzneimitteldaten aus den Jahren 2009 bis 2010. Schriftenreihe zur Gesundheitsanalyse. Band 8. St. Augustin: Asgard Verlag; 2011. 187 p"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-015-0011-z"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2013-100724"},{"issue":"10","key":"CIT0012","first-page":"A4936","volume":"61","author":"L\u00f8kkegaard E","year":"2014","journal-title":"Dan Med J"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12755"},{"key":"CIT0014","first-page":"A-1533","volume":"111","author":"Arzneimittelkommission der deutschen \u00c4rzteschaft: UAW News International","year":"2014","journal-title":"Dtsch Arztebl"},{"key":"CIT0015","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte. Checkliste f\u00fcr die Verschreibung kombinierter hormonaler Kontrazeptiva. Bonn: 2014. Available at: https:\/\/www.bfarm.de\/SharedDocs\/Risikoinformationen\/Pharmakovigilanz\/DE\/RHB\/2014\/rhb-khk.pdf [Last accessed November 5, 2017]"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1275711"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.4135\/9781412984607"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1067221"},{"key":"CIT0019","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology 2017: ATC\/DDD Index 2017. Oslo: WHO; 2017. Available at: https:\/\/www.whocc.no\/atc_ddd_index\/ [Last accessed November 5, 2017]"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2013.04.003"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.3109\/13625187.2015.1102220"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1513"},{"volume-title":"Bertelsmann Stiftung","year":"2015","author":"Nolting HD","key":"CIT0023"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2012-100376"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4304"},{"key":"CIT0026","unstructured":"arznei-telegramm 2015: Im Blickpunkt Thromboembolie: Kontrazeptiva der 3. und 4. Generation seltener verordnet \u2026in Frankreich, leider nicht in Deutschland. a-t 2015;46:41\u20132. Available at: https:\/\/www.arznei-telegramm.de\/html\/sonder\/1505041_02.html [Last accessed November 5, 2017]"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2018.1541317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T01:06:37Z","timestamp":1599354397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2018.1541317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,3]]}},"alternative-id":["10.1080\/03007995.2018.1541317"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2018.1541317","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"type":"print","value":"0300-7995"},{"type":"electronic","value":"1473-4877"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2018-06-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}